In RCC, although NPC1L1 levels were expected to be lower in advanced stages due to its reduced expression in tumor tissues compared to normal tissues, it was unexpectedly found to increase in higher stages (Figure 3A,D). Here, NPC1L1 is linked to renal cell carcinoma.